A Phase 2 Study of Enzastaurin in Participants With Follicular Lymphoma
Phase of Trial: Phase II
Latest Information Update: 15 Nov 2018
At a glance
- Drugs Enzastaurin (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 31 Aug 2018 Biomarkers information updated
- 26 Dec 2014 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
- 07 Oct 2014 Planned End Date changed from 1 Dec 2016 to 1 Mar 2015 according to ClinicalTrials.gov record.